Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference
January 06 2004 - 7:30AM
PR Newswire (US)
Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference
SAN DIEGO, Jan. 6 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,
Inc. will be presenting at the JPMorgan Healthcare Conference on
Monday, January 12, 2004 at 10:00 a.m. Pacific Time at the Westin
St. Francis Hotel in San Francisco, California. Ginger L. Graham,
President and Chief Executive Officer of Amylin Pharmaceuticals,
will be providing a corporate overview and an update on recent
company activities. This presentation will be webcast live by
JPMorgan, and a recording will be made available following the
presentation. The webcast and the recording will be accessible
through Amylin's corporate website, located at
http://www.amylin.com/ . To access the live webcast, please log on
to Amylin's site approximately fifteen minutes prior to the
presentation to register and download any necessary audio software.
Amylin Pharmaceuticals is committed to improving the lives of
people with diabetes and other metabolic diseases through the
discovery, development and commercialization of innovative,
cost-effective medicines. DATASOURCE: Amylin Pharmaceuticals, Inc.
CONTACT: Mark G. Foletta, Vice President of Finance and Chief
Financial Officer of Amylin Pharmaceuticals, Inc., +1-858-552-2200
Web site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024